Screener › Biotech Small Cap Stocks
Biotech Small Cap Stocks
Small and micro cap biotech stocks under $5B market cap — high-risk, high-reward pipeline plays in gene therapy, oncology, rare diseases, and precision medicine.
| Ticker | Company | Price | Mkt Cap | Upside | 52W Pos. | Smart Money |
|---|---|---|---|---|---|---|
| ACAD | Acadia Pharmaceuticals | $29.04 -3.87% | $4.97B | 16.6% | 83% | — |
| HAE | Haemonetics Corporation | $108.20 -0.19% | $4.92B | -3.8% | 97.8% | — |
| LFST | LifeStance Health Group, Inc. | $12.65 -1.4% | $4.83B | 9.1% | 96.2% | — |
| WAY | Waystar Holding Corp. | $24.84 +0% | $4.76B | 33.6% | 31.3% | — |
| EWTX | Edgewise Therapeutics | $43.29 -6.78% | $4.7B | 19.4% | 85.3% | — |
| DOCS | Doximity, Inc. | $25.95 +0.78% | $4.63B | 13.3% | 14.8% | — |
| ICUI | ICU Medical, Inc. | $182.53 -2.53% | $4.56B | 5.9% | 87.2% | — |
| FOLD | Amicus Therapeutics | $14.49 +0% | $4.55B | 0.1% | 99.9% | — |
| INDV | Indivior Pharmaceuticals, Inc. | $37.78 -3.23% | $4.46B | 29.7% | 75.6% | — |
| CON | Concentra Group Holdings Parent | $34.82 +0.32% | $4.44B | 14.5% | 93.8% | — |
| NVST | Envista Holdings | $26.94 -2.32% | $4.33B | 13.5% | 70.1% | — |
| LIVN | LivaNova PLC | $78.21 -3.25% | $4.31B | 14.3% | 79.6% | — |
| ITGR | Integer Holdings Corporation | $125.20 -0.08% | $4.25B | -2.7% | 98.5% | — |
| IRTC | iRhythm Technologies | $127.98 +2.59% | $4.22B | 38.2% | 24.4% | — |
| IOVA | Iovance Biotherapeutics | $8.99 +12.52% | $4.07B | 3.8% | 95.1% | — |
| VKTX | Viking Therapeutics | $34.36 -4.5% | $4.01B | 168.9% | 56.5% | — |
| DNLI | Denali Therapeutics | $24.95 -2.88% | $3.99B | 42% | 84% | — |
| CPRX | Catalyst Pharmaceuticals, Inc. | $31.49 +0% | $3.85B | 0.6% | 92.1% | — |
| RCUS | Arcus Biosciences, Inc. | $29.51 -2.77% | $3.76B | 29.9% | 89.8% | — |
| NHC | National HealthCare Corporation | $235.83 +0.76% | $3.69B | — | 97.3% | — |
| OGN | Organon & Co. | $13.73 +0.04% | $3.61B | -18.1% | 99.9% | — |
| OPCH | Option Care Health, Inc. | $23.49 +0.6% | $3.52B | 21.7% | 29.2% | — |
| FIE.DE | Fielmann | $41.80 +0.12% | $3.51B | 40.3% | 16.7% | — |
| SFZN.SW | Siegfried Holding | $78.15 -0.51% | $3.42B | 27.2% | 35.8% | — |
| VCYT | Veracyte, Inc. | $41.79 -0.95% | $3.36B | 38.4% | 41.5% | — |
| ARQT | Arcutis Biotherapeutics | $25.35 -4.2% | $3.19B | 45.5% | 61.5% | — |
| TMDX | TransMedics Group | $90.85 -3.32% | $3.14B | 7.1% | 32.1% | — |
| CLDX | Celldex Therapeutics | $39.94 -4.22% | $3.14B | 45.4% | 79% | — |
| BEAM | Beam Therapeutics | $28.39 -2.34% | $2.93B | 83.7% | 56.4% | — |
| ZLAB | Zymeworks | $26.02 -2.62% | $2.92B | 24.5% | 51.6% | — |
| VIRP.PA | Virbac | $330.00 -0.15% | $2.77B | 24.8% | 36.4% | — |
| SUPN | Supernus Pharmaceuticals, Inc. | $47.45 -2.25% | $2.76B | 30.1% | 29% | — |
| PRVA | Privia Health Group, Inc. | $21.20 -1.35% | $2.71B | 49.4% | 18% | — |
| ALHC | Alignment Healthcare | $12.93 +1.17% | $2.68B | 86.2% | 1.9% | — |
| NEOG | Neogen Corporation | $11.83 -2.63% | $2.58B | 9.9% | 87.2% | — |
| NKTR | Nektar Therapeutics | $74.53 -2.04% | $2.54B | 105.6% | 58.2% | — |
| ACHC | Acadia Healthcare Company, Inc. | $26.97 -1.43% | $2.51B | 23.8% | 63.7% | — |
| OCUL | Ocular Therapeutix | $11.09 -5.46% | $2.44B | 144.3% | 47.6% | — |
| TECN.SW | Tecan Group | $197.00 +3.03% | $2.43B | -7.3% | 94.5% | — |
| PBH | Prestige Consumer Healthcare In | $50.52 -2.24% | $2.39B | 34.2% | 27.8% | — |
| UFPT | UFP Technologies | $304.25 -2.75% | $2.36B | 16.7% | 79.1% | — |
| ADUS | Addus HomeCare Corporation | $120.55 +0.44% | $2.25B | 11.7% | 89.3% | — |
| HRMY | Harmony Biosciences Holdings, I | $38.07 -4.66% | $2.22B | 21.1% | 81.8% | — |
| ADMA | ADMA Biologics | $9.76 -2.89% | $2.19B | 74.2% | 19.2% | — |
| VCEL | Vericel Corporation | $42.11 -3.35% | $2.16B | 43.8% | 64.6% | — |
| NEO | NeoGenomics, Inc. | $16.53 -0.75% | $2.15B | 19.3% | 96.4% | — |
| XRAY | DENTSPLY SIRONA Inc. | $10.78 -2.27% | $2.15B | 26.1% | 25.1% | — |
| MD | Pediatrix Medical Group, Inc. | $26.22 +0% | $2.13B | 0.4% | 85.9% | — |
| DRW3.DE | Draegerwerk | $110.40 -0.36% | $2.07B | -4.9% | 92.6% | — |
| NVCR | NovoCure | $17.77 -2.36% | $2.07B | 52.8% | 68.4% | — |
| SEM | Select Medical Holdings Corpora | $16.51 -0.12% | $2.05B | -0.1% | 91% | — |
| SRPT | Sarepta Therapeutics | $19.22 -2.58% | $2.03B | 14.9% | 42.7% | — |
| AGIO | Agios Pharmaceuticals | $33.63 -4.24% | $2.01B | 36% | 47.9% | — |
| XNCR | Xencor | $27.00 -1.89% | $2.01B | 7.4% | 96.6% | — |
| PGNY | Progyny, Inc. | $25.96 +1.68% | $1.99B | 31% | 58.1% | — |
| DMP.DE | Dermapharm Holding | $39.90 -0.99% | $1.98B | 26.3% | 40.6% | — |
| ASTH | Astrana Health Inc. | $38.74 -1.68% | $1.92B | 32.9% | 61.6% | — |
| CMPS | COMPASS Pathways | $13.82 -1.36% | $1.91B | 71.9% | 86.1% | — |
| PRGO | Perrigo Company plc | $13.70 -1.86% | $1.9B | 20.4% | 29.1% | — |
| LMAT | LeMaitre Vascular | $82.32 -1.55% | $1.88B | 30% | 9.3% | — |
| DVAX | Dynavax Technologies | $15.50 +0% | $1.82B | 3.2% | 50% | — |
| BLFS | BioLife Solutions, Inc. | $36.97 +1.37% | $1.81B | -15.4% | 94.4% | — |
| PSNL | Personalis | $16.88 +6.77% | $1.8B | -17.8% | 98.6% | — |
| RXRX | Recursion Pharmaceuticals | $3.34 -4.57% | $1.79B | 116.1% | 12.9% | — |
| ANIP | ANI Pharmaceuticals, Inc. | $77.32 -0.9% | $1.78B | 40.2% | 24.4% | — |
| INSP | Inspire Medical Systems, Inc. | $61.27 -0.68% | $1.77B | -1.4% | 20.7% | — |
| FTRE | Fortrea Holdings Inc. | $18.19 +0.28% | $1.73B | 13% | 77.1% | — |
| ANAB | AnaptysBio | $56.69 -4.34% | $1.68B | 53.6% | 74.3% | — |
| OMCL | Omnicell | $35.50 -2.55% | $1.62B | 63% | 24.8% | — |
| AZTA | Azenta, Inc. | $36.51 +2.5% | $1.6B | -4.7% | 79.8% | — |
| HCSG | Healthcare Services Group, Inc. | $23.00 +0.31% | $1.58B | 17.4% | 74.1% | — |
| TNDM | Tandem Diabetes Care | $22.57 -3.79% | $1.57B | 27.2% | 63.1% | — |
| VIR | Vir Biotechnology, Inc. | $9.21 -5.73% | $1.56B | 128% | 66.9% | — |
| CNMD | Conmed Corporation | $51.38 +0.25% | $1.54B | -11.4% | 79.1% | — |
| INVA | Innoviva | $21.00 -2.23% | $1.52B | 66.7% | 51.9% | — |
| ENOV | Enovis Corporation | $26.18 -1.21% | $1.51B | 56% | 46.5% | — |
| SDGR | Schrodinger | $19.58 -1.36% | $1.46B | 9.4% | 71.5% | — |
| ATEC | Alphatec Holdings | $9.29 -4.72% | $1.43B | 69.9% | 15% | — |
| PAHC | Phibro Animal Health Corporatio | $35.18 -0.73% | $1.43B | 27.9% | 21.8% | — |
| FAE.MC | Faes Farma | $4.55 +0.89% | $1.42B | 17.7% | 33.6% | — |
| NVAX | Novavax | $8.42 -4.21% | $1.39B | 66.3% | 38.5% | — |
| MNKD | MannKind Corporation | $4.26 -3.07% | $1.37B | 87.1% | 47.4% | — |
| AORT | Artivion, Inc. | $27.98 -2.91% | $1.36B | 50.6% | 30.3% | — |
| AMN | AMN Healthcare Services Inc | $34.79 -1.5% | $1.35B | 2.3% | 89.1% | — |
| CERT | Certara | $8.73 +4.43% | $1.33B | -6.2% | 45.4% | — |
| IART | Integra LifeSciences Holdings C | $16.59 -3.77% | $1.29B | 17.9% | 66.9% | — |
| CRVS | Corvus Pharmaceuticals | $14.33 -6.95% | $1.21B | 131.3% | 42.4% | — |
| AVNS | Avanos Medical, Inc. | $24.99 +0.04% | $1.17B | — | 96.9% | — |
| USPH | US Physical Therapy | $78.00 -1.53% | $1.16B | 21.8% | 56.1% | — |
| STAA | STAAR Surgical Company | $23.07 -6.45% | $1.16B | 20.9% | 36.9% | — |
| OPK | OPKO Health | $1.46 +0% | $1.09B | 199.7% | 64% | — |
| QDEL | QuidelOrtho Corporation | $14.85 +7.61% | $1.02B | -1.2% | 19.2% | — |
| ARDX | Ardelyx | $3.90 -3.23% | $1.01B | 230.8% | 0.9% | — |
| PCRX | Pacira BioSciences, Inc. | $23.83 -2.18% | $937.7M | 25.9% | 56.8% | — |
| CBAV.MC | Clinica Baviera | $58.40 -2.01% | $936M | — | 83.6% | — |
| AMPH | Amphastar Pharmaceuticals, Inc. | $21.68 -0.28% | $922.2M | 3.8% | 34.4% | — |
| INMD | InMode | $14.92 -0.8% | $858.6M | 8.4% | 54.7% | — |
| COLL | Collegium Pharmaceutical, Inc. | $27.54 -4.18% | $853.7M | 80.1% | 8.2% | — |
| HSTM | HealthStream | $28.59 +0.14% | $836M | 20.7% | 78.3% | — |
| AHCO | AdaptHealth Corp. | $5.39 -4.77% | $733.3M | 69.6% | 2.2% | — |
| CTKB | Cytek Biosciences, Inc. | $4.66 -0.85% | $605.7M | 19.4% | 47.6% | — |
| EVT.DE | Evotec | $3.36 -1.41% | $596.3M | 36.6% | 4.4% | — |
| WEAV | Weave Communications | $7.29 -0.27% | $583.2M | 3.2% | 78.8% | — |
| LBIRD.PA | Lumibird | $26.15 -2.43% | $577M | 23% | 80.3% | — |
| EOLS | Evolent Health | $8.35 -2.91% | $551.5M | 79.6% | 93% | — |
| PRLD | Prelude Therapeutics | $6.50 +12.46% | $517.7M | 23.1% | 97.4% | — |
| CCCC | C4 Therapeutics | $4.03 -4.28% | $495.8M | 230.9% | 67.2% | — |
| EDIT | Editas Medicine | $2.94 -9.54% | $451.5M | 104.1% | 44.5% | — |
| REG1V.HE | Revenio Group | $14.26 -1.79% | $414.8M | 35.9% | 17.2% | — |
| PACB | Pacific Biosciences | $1.23 -3.15% | $382.3M | 86.3% | 9.6% | — |
| FYB.DE | Formycon | $18.66 -0.43% | $329.8M | 112.6% | 25.7% | — |
| EMBC | Embecta Corp | $5.47 +0.92% | $309.9M | -26.9% | 21.1% | — |
| FATE | Fate Therapeutics | $2.45 -7.55% | $293.6M | 134.5% | 66.1% | — |
| TMCI | Treace Medical Concepts | $4.46 -2.19% | $290.1M | 23.3% | 49.8% | — |
| SBS.DE | Stratec | $21.60 +1.17% | $262.6M | 18.5% | 31.5% | — |
| RNA | Avidity Biosciences | $13.48 -1.68% | $230.6M | 85.5% | 41.7% | — |
| AMWL | Amwell | $11.79 -4.92% | $197M | 8.6% | 77.1% | — |
| CRBU | Caribou Biosciences | $1.61 -1.83% | $172.6M | 636.5% | 10.7% | — |
| VXRT | Vaxart | $0.52 +6% | $126.2M | 541.6% | 39.5% | — |
| HCAT | Health Catalyst | $1.63 -3.55% | $122.7M | 12.5% | 23.7% | — |
| SEER | Seer Bio | $2.02 -1.46% | $111.9M | 98% | 54.7% | — |
| HYPR | Hyperfine | $0.90 +0.26% | $95.9M | 124.9% | 3.9% | — |
| NNOX | Nano-X Imaging | $0.89 -4.84% | $61.6M | 480% | 3.8% | — |
| TELA | Tela Bio | $0.64 -1.19% | $28.7M | 228.5% | 9.2% | — |
| CTSO | Cytosorbents Corporation | $0.31 -12.61% | $19.6M | 663.4% | 1.5% | — |
| MARI.VI | Marinomed Biotech | $4.50 +0% | $9M | — | 12.2% | — |
Analysis and Context
This sector screener currently shows 126 stocks from the selected industry segment — updated daily. The average P/E ratio is 42.8x. The average revenue growth rate is 165.5%. Sectors move through cyclical phases strongly correlated with macro factors — interest rates, GDP growth, commodity prices, and regulatory environment all drive sector dynamics. Analysts see an average of 59.6% upside in these sector names. Compare metrics against the sector average to identify relative over- and undervaluations. Sector concentration increases portfolio risk — maintain adequate diversification across industries and business models.
Ready to invest?
Compare the best brokers for US and European stocks — fees, platforms and account types side by side.
Compare brokers →